UA27002C2 - Pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprising ranitidine salt and a bismuth carboxylate and method for its preparation - Google Patents

Pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprising ranitidine salt and a bismuth carboxylate and method for its preparation

Info

Publication number
UA27002C2
UA27002C2 UA94095782A UA94095782A UA27002C2 UA 27002 C2 UA27002 C2 UA 27002C2 UA 94095782 A UA94095782 A UA 94095782A UA 94095782 A UA94095782 A UA 94095782A UA 27002 C2 UA27002 C2 UA 27002C2
Authority
UA
Ukraine
Prior art keywords
methyl
treatment
pharmaceutical composition
dosage form
oral administration
Prior art date
Application number
UA94095782A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Стефен ДУГЛАС
Колін ХЕППЕHСТОЛЛ
Hорман СМІТ
Original Assignee
Глаксо Груп Лімітед
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксо Груп Лімітед, Глаксо Груп Лимитед filed Critical Глаксо Груп Лімітед
Priority claimed from PCT/EP1992/000498 external-priority patent/WO1993017679A1/en
Publication of UA27002C2 publication Critical patent/UA27002C2/en

Links

Abstract

A pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprises as a active agent a N-[2-[[[5-[(dimethylamino)methyl]-2- furanyl]methyl]thio]ethyl]-N'-methyl-2 -nitro-1, 1-ethenediamine 2-hydroxy-1,2,3-propanetricarboxylate bismuth (3+) complex or N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2 -nitro-1, 1-ethenediamine [R-(R*R*)]-2 3-dihydroxybutanedioate bismuth (3+) complex. Additionally the composition comprises from 2 % to 20 % of alkaline salt.
UA94095782A 1992-03-05 1992-03-05 Pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprising ranitidine salt and a bismuth carboxylate and method for its preparation UA27002C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (1)

Publication Number Publication Date
UA27002C2 true UA27002C2 (en) 2000-02-28

Family

ID=74504186

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94095782A UA27002C2 (en) 1992-03-05 1992-03-05 Pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprising ranitidine salt and a bismuth carboxylate and method for its preparation

Country Status (1)

Country Link
UA (1) UA27002C2 (en)

Similar Documents

Publication Publication Date Title
RU93057724A (en) PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARATION AND METHOD OF TREATMENT
CA2096575A1 (en) Novel simethicone containing pharmaceutical compositions
EP2011484A3 (en) Use of a dry powder composition of formoterol in the treatment of chronic obstructive pulmonary disease
KR910002826A (en) Furan derivatives
MY125662A (en) Pharmaceutical formulations containing darifenacin
DE69225421T2 (en) Medicines containing sumatriptan
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
BE901073A (en) ANTIDIURETIC COMPOSITION FOR ORAL USE.
NO941276D0 (en) Lipophilic, oligosaccharide antibiotic salt preparations
KR920005984A (en) Pharmaceutical Compositions Containing Furan Derivatives
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
RU94040869A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RANITIDINE SALTS AND BISMUTH CARBOXYLATES AND THE METHOD FOR PRODUCING THEM
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
KR910014124A (en) Swallowable Dosage Units Containing Colloidal Bismuth Subcitrate (CBS)
DE69736554D1 (en) OPHTHALMIC MEDICINAL COMPOSITION
PH27446A (en) Compound with gastric acid inhibitory effect
UA27002C2 (en) Pharmaceutical composition in solid unit dosage form adapted for oral administration for treatment of gastrointestinal tract upset comprising ranitidine salt and a bismuth carboxylate and method for its preparation
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
FR2581873B1 (en) PHARMACEUTICAL PREPARATIONS WITH ANTI-HYPERTENSIVE AND CARDIOPROTECTIVE ACTIVITY CONTAINING VERAPAMIL, TRIAMTERENE AND HYDROCHLOROTHIAZIDE
RU98101105A (en) NEW APPLICATION FOR MEDICAL PURPOSES
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
RU92004583A (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARATION
KR870011135A (en) Cis-6- (4-acetanilideo) -8,9-dimethoxy-2-methyl-1,2,3,4,4a, 10b-hexedro-benzo [c] [1,6] to naphthyridine Composed pharmaceutical compositions and uses thereof